Global Biologic Excipients Market Size study, by Excipient Type (Polymers, Sugar Alcohols, Polysorbates, Inorganic Salts, Amino Acids, Surfactants, Others), by End-Use (Biopharmaceutical Manufacturers, Contract Research Organizations/Contract Manufacturing Organizations, Research Organizations) and Regional Forecasts 2022-2028
Global Biologic Excipients Market is valued at approximately USD 1.26 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.4% over the forecast period 2022-2028. Biologics are potent medicines made up of small components such as carbohydrates, proteins, DNA, or complete cells or tissues. These medications are derived from a wide range of living organisms, including mammals, birds, insects, plants, and even microorganisms. The acquisition and partnerships among established as well as emerging market players and increasing aging population and chronic diseases have led to the adoption of Biologic Excipients across the forecast period. For Instance: In November 2017, the company operating in Biologic Excipients Market entered into a partnership with DIEM Labs, to offer U.S. medical food products for the dietary management patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) and On January 31, 2020, BASF closed the acquisition of Solvay’s polyamide business. Also, with the increasing use of generic drugs and increasing demand for multi-functional biologic excipients, the adoption & demand for Biologic Excipients is likely to increase the market growth during the forecast period. However, stringent regulations impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Biologic Excipients market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing use of generic drugs that focus on delivering the highest quality and instant care to the patients. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as increase in research and development and availability of the medicine to treat symptoms instantly, expansion of the healthcare industry would create lucrative growth prospects for the Biologic Excipients market across Asia-Pacific region.
Major market players included in this report are:
Sun Pharmaceutical Industries Ltd
FMC Corporation
Wacker Chemie AG
Evonik Industries AG
Ashland Global Holdings Inc.,
Archer-Daniels-Midland Co.,
Roquette Freres S.A.,
The Dow Chemical Company,
Colorcon Inc.,
Signet Chemical Co. Pvt. Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Excipient Type:
Polymers
Sugar Alcohols
Polysorbates
Inorganic Salts
Amino Acids
Surfactants
Others
By End-Use:
Biopharmaceutical Manufacturers
Contract Research Organizations/Contract Manufacturing Organizations
Research Organizations
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Biologic Excipients Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Sun Pharmaceutical Industries Ltd
FMC Corporation
Wacker Chemie AG
Evonik Industries AG
Ashland Global Holdings Inc.,
Archer-Daniels-Midland Co.,
Roquette Freres S.A.,
The Dow Chemical Company,
Colorcon Inc.,
Signet Chemical Co. Pvt. Ltd.
Please note:The single user license is non-downloadable and non-printable. Global Site license will allow these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook